Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group

作者：Abha A. Gupta, Wei Xue, Douglas James Harrison, Douglas S. Hawkins, Roshni A. Dasgupta, Suzanne Wolden, Barry Lynn Shulkin, Amira Qumseya, Jonathan C. Routh, Tamara MacDonald, Shari L. Feinberg, Brian Crompton, Erin R. Rudzinski, Michael Arnold, Rajkumar Venkatramani · 发表于：The Lancet Oncology · 年份：2024 · DOI：10.1016/s1470-2045(24)00255-9 · 被引用次数：46 · 研究领域：Sarcoma Diagnosis and Treatment、FOXO transcription factor regulation、Glioma Diagnosis and Treatment